Leadership & Pay ·
Rigel Pharmaceuticals, Inc. announced leadership changes in its medical division
RIGLRigel Pharmaceuticals Inc
Rigel Pharmaceuticals, Inc. announced leadership changes in its medical division. Alison L. Hannah, M.D., was appointed Executive Vice President and Chief Medical Officer effective July 1, 2026, upon which she resigned from the Board of Directors. Concurrently, Lisa Rojkjaer, M.D., separated from the company as Executive Vice President and Chief Medical Officer on June 25, 2026. Rigel Pharmaceuticals is a biotechnology company focused on developing therapies for various medical conditions.